Popular Posts
-
In recent days, we are more frequently hearing about the misbranding of drugs. In many of the USFDA warning letters this word was mention... -
In 1937, the S.E. Massengill Company of Bristol, Tennessee, began selling bottles of Elixir Sulfanilamide, a liquid version of a popular ...
-
FDA Shows Flexibility in Rare Disease Drug Development Companies developing drugs for rare diseases that lack alternative treatm...
-
The laboratory environment can be a hazardous place to work. Laboratory workers are exposed to numerous potential hazards. Know the ... -
8 Mental Habits the Most Successful People Learn to Break
-
1) Fenfluramine/phentermine (Fen-Phen) Wyeth-Ayerst Laboratories Recalled: 1997 (after 24 years on the market) Financial damage: Awa...
-
Sharing an interesting article which was printed in the March 2011 issue of American Pharmaceutical Review - Volume 14, Issue 2. This wi...
-
Scientists from The Scripps Research Institute (TSRI) have deployed a powerful new drug discovery technique to identify an anti-diabetes co...
Popular Posts
-
In recent days, we are more frequently hearing about the misbranding of drugs. In many of the USFDA warning letters this word was mention...
-
In 1937, the S.E. Massengill Company of Bristol, Tennessee, began selling bottles of Elixir Sulfanilamide, a liquid version of a popular ...
-
FDA Shows Flexibility in Rare Disease Drug Development Companies developing drugs for rare diseases that lack alternative treatm...
-
The laboratory environment can be a hazardous place to work. Laboratory workers are exposed to numerous potential hazards. Know the ...
-
8 Mental Habits the Most Successful People Learn to Break
-
1) Fenfluramine/phentermine (Fen-Phen) Wyeth-Ayerst Laboratories Recalled: 1997 (after 24 years on the market) Financial damage: Awa...
-
Sharing an interesting article which was printed in the March 2011 issue of American Pharmaceutical Review - Volume 14, Issue 2. This wi...
-
Scientists from The Scripps Research Institute (TSRI) have deployed a powerful new drug discovery technique to identify an anti-diabetes co...
0 comments: